{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:39:48Z","timestamp":1783067988504,"version":"3.54.6"},"reference-count":29,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OPTH"],"DOI":"10.2147\/opth.s372312","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T08:30:11Z","timestamp":1660725011000},"page":"2669-2676","source":"Crossref","is-referenced-by-count":1,"title":["A Pooled Assessment of Ocular Surface Disease After Switching from Preserved Prostaglandins to Tafluprost Across Six Countries in Asia"],"prefix":"10.2147","volume":"Volume 16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9858-9287","authenticated-orcid":true,"given":"Joseph Anthony","family":"Tumbocon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina T","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanendthire","family":"Sangapillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6931-4409","authenticated-orcid":true,"given":"Yung-Chang","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien Han","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4342-0174","authenticated-orcid":true,"given":"Ngamkae","family":"Ruangvaravate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/bjophthalmol-2014-306102","volume":"100","author":"Chan","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"European Glaucoma Society. Terminology and guidelines for glaucoma 4th edition - Chapter 3: treatment principles and options supported by the egs foundation: part 1: foreword; introduction; glossary; chapter 3 treatment principles and options. Br J Ophthalmol. 2017;101(6):130\u2013195. doi:10.1136\/bjophthalmol-2016-EGSguideline.003","DOI":"10.1136\/bjophthalmol-2016-EGSguideline.003"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"6509809","DOI":"10.1155\/2016\/6509809","volume":"2016","author":"Harasymowycz","year":"2016","journal-title":"J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/OPX.0b013e3182058ead","volume":"88","author":"Realini","year":"2011","journal-title":"Optom Vis Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000181","author":"Baudouin","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/112067210701700311","volume":"17","author":"Jaenen","year":"2007","journal-title":"Eur J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2147\/OPTH.S30951","volume":"7","author":"Liu","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1345\/aph.1R229","volume":"46","author":"Swymer","year":"2012","journal-title":"Ann Pharmacother"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2147\/OPTH.S41640","volume":"7","author":"Lanzl","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1007\/s12325-021-01725-7","volume":"38","author":"Ansari","year":"2021","journal-title":"Adv Ther"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"804730","DOI":"10.1100\/2012\/804730","volume":"2012","author":"Ranno","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.2147\/OPTH.S209942","volume":"13","author":"Tumbocon","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/ceo.13329","volume":"46","author":"Wong","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.2147\/OPTH.S264984","volume":"14","author":"Ruangvaravate","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.35119\/myjo.v3i3.185","volume":"3","author":"Lim","year":"2021","journal-title":"Malays J Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/ph15020201","volume":"15","author":"Park","year":"2022","journal-title":"Pharmaceuticals"},{"key":"ref18","unstructured":"Yen YC. Prospective, single center switching study of 0.0015% tafluprost ophthalmic solution in primary open-angle glaucoma and ocular hypertension patients with corneal disorders (Switching from 0.005% latanoprost ophthalmic solution). Poster presented at: 2021 Mid-Year Scientific Meeting of the Ophthalmological Society of Taiwan (POA-184); April 10\u201311; 2021; Kaohsiung, Taiwan."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2332\/allergolint.11-RAI-0335","volume":"60","author":"Takamura","year":"2011","journal-title":"Allergol Int"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40779-020-00238-8","volume":"7","author":"Ma","year":"2020","journal-title":"Mil Med Res"},{"key":"ref21","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, Oxman A. GRADE handbook for grading quality of evidence and strength of recommendations. Gdt.guidelinedevelopment.org. Available from: http:\/\/gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html. Accessed August 20, 2021."},{"key":"ref22","unstructured":"GRADEpro GDT. GRADEpro guideline development tool [software]. McMaster University, (developed by Evidence Prime, Inc.); 2020. Available from: gradepro.org. Accessed August 11, 2022."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1755-3768.2008.01381.x","volume":"242","author":"Hamacher","year":"2008","journal-title":"Acta Ophthalmol Suppl"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s12325-017-0549-0","volume":"34","author":"Kuwayama","year":"2017","journal-title":"Adv Ther"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12325-011-0038-9","volume":"28","author":"Erb","year":"2011","journal-title":"Adv Ther"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/1120672117753703","volume":"28","author":"Hommer","year":"2018","journal-title":"Eur J Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1755-3768.2010.01907.x","volume":"88","author":"Uusitalo","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.ajo.2005.09.011","volume":"141","author":"Wilensky","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/108076803762718088","volume":"19","author":"Feldman","year":"2003","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["Clinical Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=83093","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=83093","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T08:30:15Z","timestamp":1660725015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/a-pooled-assessment-of-ocular-surface-disease-after-switching-from-pre-peer-reviewed-fulltext-article-OPTH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":29,"URL":"https:\/\/doi.org\/10.2147\/opth.s372312","relation":{},"ISSN":["1177-5483"],"issn-type":[{"value":"1177-5483","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}